ArticleTrials2024

Colchicine to reduce coronavirus disease-19-related inflammation and cardiovascular complications in high-risk patients post-acute infection with SARS-COV-2-a study protocol for a randomized controlled trial.

Shani S Thankachen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.